Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial
Nishio, Makoto, Barlesi, Fabrice, West, Howard, Ball, Simon, Bordoni, Rodolfo, Cobo, Manuel, Longeras, Pascale Dubray, Goldschmidt, Jerome, Novello, Silvia, Orlandi, Francisco, Sanborn, Rachel E., Szalai, Zsuzsanna, Ursol, Grigoriy, Mendus, Diana, Wang, Lijia, Wen, Xiaohui, McCleland, Mark, Hoang, Tien, Phan, See, Socinski, Mark A.
Published in Journal of thoracic oncology (01.04.2021)
Published in Journal of thoracic oncology (01.04.2021)
Get full text
Journal Article
Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy
Wang, Kyle, Eblan, Michael J, Deal, Allison M, Lipner, Matthew, Zagar, Timothy M, Wang, Yue, Mavroidis, Panayiotis, Lee, Carrie B, Jensen, Brian C, Rosenman, Julian G, Socinski, Mark A, Stinchcombe, Thomas E, Marks, Lawrence B
Published in Journal of clinical oncology (01.05.2017)
Published in Journal of clinical oncology (01.05.2017)
Get full text
Journal Article
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
SOCINSKI, Mark A, BONDARENKO, Igor, IGLESIAS, Jose L, RENSCHLER, Markus F, KARASEVA, Nina A, MAKHSON, Anatoly M, VYNNYCHENKO, Igor, OKAMOTO, Isamu, HON, Jeremy K, HIRSH, Vera, BHAR, Paul, HUI ZHANG
Published in Journal of clinical oncology (10.06.2012)
Published in Journal of clinical oncology (10.06.2012)
Get full text
Journal Article
Dabrafenib in patients with BRAFV600E -positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial
Planchard, David, MD, Kim, Tae Min, MD, Mazieres, Julien, Prof, Quoix, Elisabeth, Prof, Riely, Gregory, MD, Barlesi, Fabrice, Prof, Souquet, Pierre-Jean, MD, Smit, Egbert F, Prof, Groen, Harry J M, Prof, Kelly, Ronan J, MD, Cho, B C, MD, Socinski, Mark A, Prof, Pandite, Lini, MD, Nase, Christine, BSN, Ma, Bo, PhD, D'Amelio, Anthony, PhD, Mookerjee, Bijoyesh, MD, Curtis, C Martin, BS, Johnson, Bruce E, Prof
Published in The lancet oncology (01.05.2016)
Published in The lancet oncology (01.05.2016)
Get full text
Journal Article
Alectinib in ALK -positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial
Shaw, Alice T, Dr, Gandhi, Leena, MD, Gadgeel, Shirish, Prof, Riely, Gregory J, MD, Cetnar, Jeremy, MD, West, Howard, MD, Camidge, D Ross, MD, Socinski, Mark A, Prof, Chiappori, Alberto, MD, Mekhail, Tarek, MD, Chao, Bo H, MD, Borghaei, Hossein, DO, Gold, Kathryn A, MD, Zeaiter, Ali, MD, Bordogna, Walter, PhD, Balas, Bogdana, MD, Puig, Oscar, PhD, Henschel, Volkmar, PhD, Ou, Sai-Hong Ignatius, Prof
Published in The lancet oncology (01.02.2016)
Published in The lancet oncology (01.02.2016)
Get full text
Journal Article
Characterization of KRAS Mutation Subtypes in Non-small Cell Lung Cancer
Judd, Julia, Abdel Karim, Nagla, Khan, Hina, Naqash, Abdul Rafeh, Baca, Yasmine, Xiu, Joanne, VanderWalde, Ari M, Mamdani, Hirva, Raez, Luis E, Nagasaka, Misako, Pai, Sachin Gopalkrishna, Socinski, Mark A, Nieva, Jorge J, Kim, Chul, Wozniak, Antoinette J, Ikpeazu, Chukwuemeka, de Lima Lopes, Jr, Gilberto, Spira, Alexander I, Korn, W Michael, Kim, Edward S, Liu, Stephen V, Borghaei, Hossein
Published in Molecular cancer therapeutics (01.12.2021)
Published in Molecular cancer therapeutics (01.12.2021)
Get full text
Journal Article
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
Thatcher, Nick, Prof, Hirsch, Fred R, Prof, Luft, Alexander V, MD, Szczesna, Aleksandra, MD, Ciuleanu, Tudor E, Prof, Dediu, Mircea, MD, Ramlau, Rodryg, Prof, Galiulin, Rinat K, MD, Bálint, Beatrix, MD, Losonczy, György, Prof, Kazarnowicz, Andrzej, MD, Park, Keunchil, MD, Schumann, Christian, Prof, Reck, Martin, MD, Depenbrock, Henrik, MD, Nanda, Shivani, MS, Kruljac-Letunic, Anamarija, PhD, Kurek, Raffael, MD, Paz-Ares, Luis, MD, Socinski, Mark A, Prof
Published in The lancet oncology (01.07.2015)
Published in The lancet oncology (01.07.2015)
Get full text
Journal Article
Web Resource
Personalized Medicine in Non–Small-Cell Lung Cancer: Is KRAS a Useful Marker in Selecting Patients for Epidermal Growth Factor Receptor–Targeted Therapy?
ROBERTS, Patrick J, STINCHCOMBE, Thomas E, DER, Channing J, SOCINSKI, Mark A
Published in Journal of clinical oncology (01.11.2010)
Published in Journal of clinical oncology (01.11.2010)
Get full text
Journal Article
PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer
PATEL, Jyoti D, SOCINSKI, Mark A, GUBA, Susan C, JINGYI LIU, FRIMODT-MOLLER, Bente, JOHN, William J, OBASAJU, Coleman K, PENNELLA, Eduardo J, BONOMI, Philip, GOVINDAN, Ramaswamy, GARON, Edward B, REYNOLDS, Craig H, SPIGEL, David R, OLSEN, Mark R, HERMANN, Robert C, JOTTE, Robert M, BECK, Thaddeus, RICHARDS, Donald A
Published in Journal of clinical oncology (01.12.2013)
Published in Journal of clinical oncology (01.12.2013)
Get full text
Journal Article
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial
Butts, Charles, Dr, Socinski, Mark A, Prof, Mitchell, Paul L, MD, Thatcher, Nick, Prof, Havel, Libor, MD, Krzakowski, Maciej, Prof, Nawrocki, Sergiusz, MD, Ciuleanu, Tudor-Eliade, MD, Bosquée, Lionel, MD, Trigo, José Manuel, MD, Spira, Alexander, MD, Tremblay, Lise, MD, Nyman, Jan, MD, Ramlau, Rodryg, MD, Wickart-Johansson, Gun, MD, Ellis, Peter, MD, Gladkov, Oleg, MD, Pereira, José Rodrigues, MD, Eberhardt, Wilfried Ernst Erich, MD, Helwig, Christoph, Dipl Stat, Schröder, Andreas, MD, Shepherd, Frances A, Prof
Published in The lancet oncology (2014)
Published in The lancet oncology (2014)
Get full text
Journal Article
Web Resource
Impact of PD-L1 expression, driver mutations and clinical characteristics on survival after anti-PD-1/PD-L1 immunotherapy versus chemotherapy in non-small-cell lung cancer: A meta-analysis of randomized trials
Huang, Qingyuan, Zhang, Hua, Hai, Josephine, Socinski, Mark A., Lim, Eric, Chen, Haiquan, Stebbing, Justin
Published in Oncoimmunology (02.12.2018)
Published in Oncoimmunology (02.12.2018)
Get full text
Journal Article
Molecular Predictors of Outcome With Gefitinib and Docetaxel in Previously Treated Non–Small-Cell Lung Cancer: Data From the Randomized Phase III INTEREST Trial
DOUILLARD, Jean-Yves, SHEPHERD, Frances A, WATKINS, Claire L, SPEAKE, Georgina, ARMOUR, Alison A, KIM, Edward S, HIRSH, Vera, MOK, Tony, SOCINSKI, Mark A, GERVAIS, Radj, LIAO, Mei-Lin, BISCHOFF, Helge, RECK, Martin, SELLERS, Mark V
Published in Journal of clinical oncology (10.02.2010)
Published in Journal of clinical oncology (10.02.2010)
Get full text
Journal Article
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial
Kim, Edward S, MD, Hirsh, Vera, MD, Mok, Tony, Prof, Socinski, Mark A, Prof, Gervais, Radj, MD, Wu, Yi-Long, Prof, Li, Long-Yun, Prof, Watkins, Claire L, MSc, Sellers, Mark V, MSc, Lowe, Elizabeth S, MD, Sun, Yan, MD, Liao, Mei-Lin, Prof, Østerlind, Kell, MD, Reck, Martin, MD, Armour, Alison A, FRCR, Shepherd, Frances A, Prof, Lippman, Scott M, Prof, Douillard, Jean-Yves, Prof
Published in The Lancet (British edition) (22.11.2008)
Published in The Lancet (British edition) (22.11.2008)
Get full text
Journal Article
Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung cancer with STK11, KEAP1, or TP53 comutations: subgroup results from the phase III IMpower150 trial
West, Howard Jack, McCleland, Mark, Cappuzzo, Federico, Reck, Martin, Mok, Tony SK, Jotte, Robert M, Nishio, Makoto, Kim, Eugene, Morris, Stefanie, Zou, Wei, Shames, David, Das Thakur, Meghna, Shankar, Geetha, Socinski, Mark A
Published in Journal for immunotherapy of cancer (01.02.2022)
Published in Journal for immunotherapy of cancer (01.02.2022)
Get full text
Journal Article
Randomized Phase II Trial of Erlotinib Alone or With Carboplatin and Paclitaxel in Patients Who Were Never or Light Former Smokers With Advanced Lung Adenocarcinoma: CALGB 30406 Trial
JÄNNE, Pasi A, XIAOFEI WANG, VOKES, Everett E, MILLER, Vincent A, SOCINSKI, Mark A, CRAWFORD, Jeffrey, STINCHCOMBE, Thomas E, LIN GU, CAPELLETTI, Marzia, EDELMAN, Martin J, VILLALONA-CALERO, Miguel A, KRATZKE, Robert
Published in Journal of clinical oncology (10.06.2012)
Published in Journal of clinical oncology (10.06.2012)
Get full text
Journal Article
Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancer
Wang, Kyle, Pearlstein, Kevin A., Patchett, Nicholas D., Deal, Allison M., Mavroidis, Panayiotis, Jensen, Brian C., Lipner, Matthew B., Zagar, Timothy M., Wang, Yue, Lee, Carrie B., Eblan, Michael J., Rosenman, Julian G., Socinski, Mark A., Stinchcombe, Thomas E., Marks, Lawrence B.
Published in Radiotherapy and oncology (01.11.2017)
Published in Radiotherapy and oncology (01.11.2017)
Get full text
Journal Article
Randomized Phase II Study of Bevacizumab in Combination With Chemotherapy in Previously Untreated Extensive-Stage Small-Cell Lung Cancer: Results From the SALUTE Trial
SPIGEL, David R, TOWNLEY, Peter M, WATERHOUSE, David M, LIANG FANG, ADIGUZEL, Ibrahim, HUANG, Jane E, KARLIN, David A, FAORO, Leonardo, SCAPPATICCI, Frank A, SOCINSKI, Mark A
Published in Journal of clinical oncology (01.06.2011)
Published in Journal of clinical oncology (01.06.2011)
Get full text
Journal Article